L&C Bio Co Ltd
KOSDAQ:290650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
KR |
|
D
|
Diana Shipping Inc
F:DSZ
|
GR |
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
N
|
NetApp Inc
DUS:NTA
|
US |
|
Havilah Resources Ltd
ASX:HAV
|
AU |
|
Q
|
Qingdao Port International Co Ltd
XMUN:0QP
|
CN |
|
G
|
Gruppa Renessans Strakhovaniye PAO
MOEX:RENI
|
RU |
|
L
|
Linde PLC
F:LIN
|
UK |
|
ING Groep NV
F:INNA
|
NL |
|
P
|
Paccar Inc
F:PAE
|
US |
|
S
|
SoftBank Group Corp
OTC:SFTBY
|
JP |
|
R
|
Ryanair Holdings PLC
XMUN:RY4C
|
IE |
|
Ferronordic AB
STO:FNM
|
SE |
|
ALR Technologies SG Ltd
OTC:ALRTF
|
SG |
|
E
|
Eutelsat Communications SA
DUS:E3B
|
FR |
|
A
|
Anheuser-Busch Inbev SA
F:ITKA
|
BE |
|
X
|
Xero Ltd
F:0XE
|
NZ |
|
Dalaroo Metals Ltd
ASX:DAL
|
AU |
|
S
|
SSP Group PLC
OTC:SSPPF
|
UK |
|
Apyx Medical Inc
NASDAQ:APYX
|
US |
|
Phoenix Mills Ltd
NSE:PHOENIXLTD
|
IN |
|
Avolta AG
F:D2J
|
CH |
|
Fuda Alloy Materials Co Ltd
SSE:603045
|
CN |
|
Tomra Systems ASA
OTC:TMRAF
|
NO |
Bankruptcy Probability
L&C Bio Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
L&C Bio Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
1.3T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
221.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
189.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
72.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
L&C Bio Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, L&C Bio Co Ltd has total debt of 27.9B KRW. This includes both short-term (18B KRW) and long-term (9.9B KRW) debt.
You can find a full breakdown on its Balance Sheet.